AGUIRRE PÉREZ A, Avila-Luna A, Olmos-Hernández A, Verduzco-Mendoza A, Arias-Montaño JA, Bueno-Nava A. antidyskinetic effect of the H₃ agonist immepip is accompanied by a reduction in thalamic GABA levels in hemiparkinsonian rats chronically treated with L-DOPA. Invest. Discapacidad [Internet]. 2025 Nov. 11 [cited 2025 Nov. 20];11(S1). Available from: https://dsm.inr.gob.mx/indiscap/index.php/INDISCAP/article/view/480